Suppose you are involved in the administration of a community-based drug prevention program. It is an evidence-based program listed by AMHSA.
Although the program is successful in client outcomes, you
could be reaching many more addicts who need your help. Funds are
low. What do you do? Perform ________.
A. a cost-effectiveness analysis so you can show potential funders
how effective your outcomes are compared with the cost of the
program
B. a cost/benefit analysis to demonstrate the benefits of your
program outcomes in dollars and cents
C. cost/benefit and cost-effectiveness analyses so you can better
demonstrate the value of your program to potential funders
D. cost/benefit and cost-effectiveness analyses to determine the
least expensive means of operating at a higher capacity while
maintaining high outcomes
Question 2
Suppose you are a human resources specialist at a trucking company that implemented a random drug testing program to comply with state and federal laws.
The detection rates of drug abuse have increased
since implementation, but prevention rates have not changed. How
might you improve prevention rates?
A. Add an EAP that trains employees to apply peer pressure.
B. Add a peer-based substance abuse prevention program.
C. Recognize that random drug testing is the best preventive
measure you can take.
D. Add a peer-based informant program for reporting suspicious
behavior.
Cross-section of wrist showing tendons and nerves involved in carpal tunnel syndrome.
Sample tiered drug formulary for antibiotics.
Drug Classification and Description of Use
Metabolic pathways involved in the breakdown of proteins for energy.
Clinically Significant Drug-Disease Interactions in Dentistry
Alli, the nonprescription version of the drug orlistat, was approved by the FDA